Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Given Average Recommendation of "Buy" by Brokerages

[ad_1]

Shares of Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO – Get Free Report) have been assigned an average rating of “Buy” from the five analysts that are covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation and one has assigned a stro

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *